/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

G

Gudrun Pohl

Eli Lilly (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

67

Papers

1.8K

Citations

21

h-index

28

i10-index

Gudrun Pohl is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Cancer-related Molecular Pathways & Erythropoietin and Anemia Treatment. The author has an h-index of 21, co-authored 57 publications.

Research Topics

Drug Transport and Resistance Mechanisms Cancer-related Molecular Pathways Erythropoietin and Anemia Treatment Lung Cancer Treatments and Mutations Hemoglobinopathies and Related Disorders

Papers by this author

works

Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and Colorectal Cancer Study Group

2005 · Journal of Clinical Oncology · 103 citations

https://doi.org/10.1200/jco.2005.03.033

Martin Filipits Gudrun Pohl Margaretha Rudas Otto Dietze

Expression of the multidrug resistance protein (MRP1) in breast cancer.

2000 · PubMed · 30 citations

Martin Filipits R. Malayeri R.W. Suchomel Gudrun Pohl

Research topics

topics

Drug Transport and Resistance Mechanisms

Cancer-related Molecular Pathways

Erythropoietin and Anemia Treatment

Lung Cancer Treatments and Mutations

Hemoglobinopathies and Related Disorders

Chat about Author

Papers

Chat

Click to start Chat